Literature DB >> 17440345

Fas-mediated apoptotic signal transduction in keloid and hypertrophic scar.

Feng Lu1, Jianhua Gao, Rei Ogawa, Hiko Hyakusoku, Chunquan Ou.   

Abstract

BACKGROUND: The pathogenesis of keloid and hypertrophic scar is less well understood because of the lack of animal models. The cell-surface Fas receptor, which is widely distributed in skin components, has been shown to be an important factor that induces apoptosis in human dermal fibroblasts. In this report, the authors performed a comparative study on apoptotic signal transduction in fibroblasts derived from keloids and hypertrophic scars.
METHODS: Fibroblasts harvested from 10 patients with keloids and hypertrophic scars were used for this study. At first, apoptosis induction using Fas antibody and C2-ceramide were evaluated using electron microscopy and flow cytometry. Second, the expression of the apoptosis-related proteins Fas and Bcl-2 were measured by means of flow cytometry. Third, ceramide was measured by quantitative derivatization to ceramide-1-phosphate using diacylglycerol kinase and [gamma-32P] ATP. Moreover, intercellular Ca2+ was investigated using confocal microscopic analyses.
RESULTS: In contrast to hypertrophic scar-derived fibroblasts, those derived from keloids are significantly resistant to Fas-mediated apoptosis. The intercellular ceramide and Ca were not activated. There were no significant differences in the level of expression of Bcl-2 between the two groups, but Fas expression was higher in keloid than in hypertrophic scar. Fibroblasts from the two groups were susceptible to ceramide-induced apoptosis.
CONCLUSIONS: Blocking of the Fas-mediated apoptotic pathway in keloids occurs upstream of the second messenger. The abnormal Fas-induced apoptosis in keloids may account for the imbalance of proliferation and apoptosis. Enhancement of Fas sensitivity could be a promising therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440345     DOI: 10.1097/01.prs.0000258851.47193.06

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  10 in total

1.  Keloid explant culture: a model for keloid fibroblasts isolation and cultivation based on the biological differences of its specific regions.

Authors:  Vanina Monique Tucci-Viegas; Bernardo Hochman; Jerônimo P França; Lydia M Ferreira
Journal:  Int Wound J       Date:  2010-10       Impact factor: 3.315

2.  Keloid progression: a stiffness gap hypothesis.

Authors:  Chenyu Huang; Longwei Liu; Zhifeng You; Bingjie Wang; Yanan Du; Rei Ogawa
Journal:  Int Wound J       Date:  2016-12-19       Impact factor: 3.315

3.  Identification of ASAH1 as a susceptibility gene for familial keloids.

Authors:  Regie Lyn P Santos-Cortez; Ying Hu; Fanyue Sun; Fairouz Benahmed-Miniuk; Jian Tao; Jitendra K Kanaujiya; Samuel Ademola; Solomon Fadiora; Victoria Odesina; Deborah A Nickerson; Michael J Bamshad; Peter B Olaitan; Odunayo M Oluwatosin; Suzanne M Leal; Ernst J Reichenberger
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

4.  Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts.

Authors:  Bruna De Felice; Corrado Garbi; Margherita Santoriello; Alessandra Santillo; Robert R Wilson
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

5.  ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis.

Authors:  Elisabetta Zulato; Francesca Favaretto; Caterina Veronese; Stefano Campanaro; Jan D Marshall; Sara Romano; Anna Cabrelle; Gayle B Collin; Barbara Zavan; Anna S Belloni; Enrica Rampazzo; Jürgen K Naggert; Giovanni Abatangelo; Nicola Sicolo; Pietro Maffei; Gabriella Milan; Roberto Vettor
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

Review 6.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

Review 7.  Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Exp Dermatol       Date:  2020-07-06       Impact factor: 3.960

8.  Keloid Nodule Metabolic Activity for Continuous Expansion.

Authors:  Koichi Ueda; Yuumi Lee; Yosuke Inomata; Kohei Taniguchi; Kazuhisa Uchiyama; Yuko Ito
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-08-24

Review 9.  Roles of lipid metabolism in keloid development.

Authors:  Chenyu Huang; Rei Ogawa
Journal:  Lipids Health Dis       Date:  2013-05-01       Impact factor: 3.876

10.  Keloids and hypertrophic scars: update and future directions.

Authors:  Chenyu Huang; George F Murphy; Satoshi Akaishi; Rei Ogawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2013-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.